Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors

Who is this study for? Cancer survivors with musculoskeletal pain
What treatments are being studied? Tibetree Pain Relieving Plaster
Status: Active, not recruiting
Location: See all (7) locations...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The purpose of this study is to find out whether Tibetree Pain Relieving Plaster, an herbal pain relief patch, may be able to reduce this pain. Tibetree Pain Relieving Plaster is available as an over-the-counter (non-prescription) treatment for the temporary relief of minor aches and pains in muscles and joints. This study is the first to test this treatment in people who have had cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Age ≥ 18 years or older

• A diagnosis of cancer with no restrictions placed on type of cancer or stage. Eligibility criteria will not be restricted to MSK confirmed biopsy/diagnosis. Participating institution's testing is sufficient for other study sites

• Completed active treatment (surgery, chemotherapy, and/or radiotherapy) at least one month prior to study initiation (patients on continued hormone treatment or maintenance targeted therapies will not be excluded).

• Patients currently have no evidence of disease

• Ambulatory (Karnofsky functional score of ≥ 60)

• Having a focused location of regional musculoskeletal pain (e.g. joints, extremities, back, neck) that can be covered by one patch of PRP

• Worst pain score (numeric pain rating scale) 5 or above in the preceding week

• Pain for at least 3 months and at least 15 days with pain in the preceding 30 days; and willingness to adhere to and understanding of all study-related procedures, including randomization to one of the two possible choices

• Able to understand informed consent and provide signed informed consent form

Locations
United States
New Jersey
Memoral Sloan Kettering Basking Ridge
Basking Ridge
Memoral Sloan Kettering Monmouth
Middletown
Memorial Sloan Kettering Bergen
Montvale
New York
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack
Commack
Memoral Sloan Kettering Westchester
Harrison
Memorial Sloan Kettering Cancer Center
New York
Memorial Sloan Kettering Nassau
Uniondale
Time Frame
Start Date: May 28, 2021
Estimated Completion Date: May 28, 2023
Participants
Target number of participants: 68
Treatments
Experimental: Tibetree pain relieving plaster
Participants with chronic musculoskeletal pain for ≥ 3 months and with BPI worst pain rated 5 or greater during the preceding week will be eligible for the study. We will enroll 66 participants with 33 patients in each arm.
Placebo Comparator: Placebo plaster groups
Participants with chronic musculoskeletal pain for ≥ 3 months and with BPI worst pain rated 5 or greater during the preceding week will be eligible for the study. We will enroll 66 participants with 33 patients in each arm.
Authors
Related Therapeutic Areas
Sponsors
Leads: Memorial Sloan Kettering Cancer Center

This content was sourced from clinicaltrials.gov

Similar Clinical Trials